Literature DB >> 32647947

Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic.

Raymond Pranata1, Michael Anthonius Lim2, Emir Yonas2, Bambang Budi Siswanto3, Markus Meyer4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32647947      PMCID: PMC7345450          DOI: 10.1007/s11739-020-02428-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   5.472


× No keyword cloud information.
Dear Editor, Since the outbreak of coronavirus disease 2019 (COVID-19), many health-care providers have urged patients to limit or delay non-urgent visits to minimize the risk of transmission. Despite these efforts, some health-care services have experienced an ever increasing volume of traffic. As health-care providers are prioritizing emergency and COVID-19 cases, the majority of elective procedures have been postponed indefinetly. During the COVID-19 pandemic, there has been up to 48% reduction in acute myocardial infarction-related hospitalization [1]. A study by Hammad et al. in patients with ST-segment elevation myocardial infarction showed that 27% of patients avoided hospitals due to fear of COVID-19 transmission, 18% thought that the symptoms were related to COVID-19, and 9% did not want to burden the hospital [2]. Patients that did not seek medical attention may experience higher out-of-hospital-related complications, including out-of-hospital cardiac arrest (OHCA). Cardiopulmonary resuscitation (CPR) hypothetically carries the risk of COVID-19 transmission and may reduce willingness to perform CPR without personal protective equipment [3]. Bystanders with advanced age and comorbidities who are at risk for severe infection might be discouraged even more [4-9]. We aimed to assess the effect of the COVID-19 pandemic on the characteristics, circumstances, and prognosis of OHCA. We performed a systematic literature search from PubMed and medRvix from inception up until 5 June 2020 using the keyword (“cardiac arrest” AND (“COVID-19” OR “SARS-CoV-2” OR “2019-nCov” OR “pandemic”)). The inclusion criteria were studies that compared OHCA in 2020 to previous years and reported any of the following: (1) proportion of out-of-hospital mortality, (2) proportion of unwitnessed cardiac arrest, (3) proportion of bystander CPR, or (4) proportion of shockable rhythm. We excluded studies without key outcomes, case reports, and articles without primary data. Statistical analysis was performed using RevMan 5.3 (Cochrane Collaboration). Odds ratios (ORs) were calculated using the Mantel–Haenszel formula with the random-effects model regardless of heterogeneity. There were 148 results, 140 of which were excluded through title and abstract screening. Full-text articles from the remaining eight records were assessed. We excluded six articles because of (1) cardiac events in general (n = 1), (2) insufficient data for analysis (n = 3), and (3) assessing transmission to medical personnel (n = 2). Two studies were included in the quantitative synthesis [10, 11]. For analysis, 883 OHCA patients from the pandemic in 2020 were included; the comparator group included 2019 (Baldi et al., Italy) and weeks 12–17 of each year from 2012 to 2019 (Marijon et al., France). The total number of OHCA cases was higher in the year 2020 (883 vs. 764) compared to 2019. During the pandemic, out-of-hospital mortality was higher (OR 2.07 [1.65, 2.61], p < 0.001; I2: 0%, p = 0.60) (Fig. 1). The rate of unwitnessed cardiac arrest was higher (OR 1.36 [1.15, 1.61], p < 0.001; I2: 0%, p = 0.32) during the pandemic and the rates of bystander CPR (OR 0.52 [0.43, 0.62], p < 0.001; I2: 0%, p = 0.99) and shockable rhythm were lower (OR 0.45 [0.34, 0.60], p < 0.001; I2: 0%, p = 0.48).
Fig. 1

Meta-analysis of characteristics, circumstances, and prognosis of OHCA. Forest plots showing mortality (a), unwitnessed cardiac arrest (b), bystander CPR (c), and shockable rhythm (d). CPR cardiopulmonary resustication, OHCA out-of-hospital cardiac arrest

Meta-analysis of characteristics, circumstances, and prognosis of OHCA. Forest plots showing mortality (a), unwitnessed cardiac arrest (b), bystander CPR (c), and shockable rhythm (d). CPR cardiopulmonary resustication, OHCA out-of-hospital cardiac arrest There are several explanations for increased OHCA-associated mortality during the pandemic; the first is due to increased unwitnessed cardiac arrest, as shown in the meta-analysis. Due to a stay at home order during this time, people who live alone are at higher risk of unwitnessed cardiac events. Unwitnessed cardiac arrest prolonged the time from collapse to CPR, which is associated with poorer outcomes [12]. Second, the rate of bystander CPR was halved compared to the non-pandemic period; the looming possibility of COVID-19 transmission may cause hesitancy to perform CPR. Waiting for emergency medical services to arrive to perform CPR causes delays, and resuscitation might be futile in some cases. Third, the rate of shockable rhythm was lower during the pandemic. Initial non-shockable rhythms generally have a poorer prognosis compared to shockable rhythms [13]. Prolonged time to shock delivery also leads to worsened prognosis [13]. Fourth, emergency medical service arrival time was also delayed, with a median of 15 min vs. 12 min in the Baldi et al. study and 10.4 min vs. 9.4 min in the study by Marijon et al. [10, 11]. Hesitant bystanders, along with delayed emergency medical services arrival, prolongs the time from collapse to CPR and time to shock delivery. The combination of these factors leads to a poor prognosis. In conclusion, the COVID-19 pandemic was associated with higher OHCA-related mortality. The numbers might be even higher in developing countries due to poor health-care and emergency medical service systems.
  12 in total

1.  Different Impacts of Time From Collapse to First Cardiopulmonary Resuscitation on Outcomes After Witnessed Out-of-Hospital Cardiac Arrest in Adults.

Authors:  Masahiko Hara; Kenichi Hayashi; Shungo Hikoso; Yasushi Sakata; Tetsuhisa Kitamura
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-04-29

2.  Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19.

Authors:  R Pranata; A Y Soeroto; I Huang; M A Lim; P Santoso; H Permana; A A Lukito
Journal:  Int J Tuberc Lung Dis       Date:  2020-08-01       Impact factor: 2.373

3.  Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study.

Authors:  Eloi Marijon; Nicole Karam; Daniel Jost; David Perrot; Benoit Frattini; Clément Derkenne; Ardalan Sharifzadehgan; Victor Waldmann; Frankie Beganton; Kumar Narayanan; Antoine Lafont; Wulfran Bougouin; Xavier Jouven
Journal:  Lancet Public Health       Date:  2020-05-27

4.  Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.

Authors:  Raymond Pranata; Ian Huang; Antonia Anna Lukito; Sunu Budhi Raharjo
Journal:  Postgrad Med J       Date:  2020-05-20       Impact factor: 2.401

5.  Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.

Authors:  Raymond Pranata; Michael Anthonius Lim; Ian Huang; Sunu Budhi Raharjo; Antonia Anna Lukito
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

6.  Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy.

Authors:  Enrico Baldi; Giuseppe M Sechi; Claudio Mare; Fabrizio Canevari; Antonella Brancaglione; Roberto Primi; Catherine Klersy; Alessandra Palo; Enrico Contri; Vincenza Ronchi; Giorgio Beretta; Francesca Reali; Pierpaolo Parogni; Fabio Facchin; Davide Bua; Ugo Rizzi; Daniele Bussi; Simone Ruggeri; Luigi Oltrona Visconti; Simone Savastano
Journal:  N Engl J Med       Date:  2020-04-29       Impact factor: 91.245

7.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.

Authors:  Salvatore De Rosa; Carmen Spaccarotella; Cristina Basso; Maria Pia Calabrò; Antonio Curcio; Pasquale Perrone Filardi; Massimo Mancone; Giuseppe Mercuro; Saverio Muscoli; Savina Nodari; Roberto Pedrinelli; Gianfranco Sinagra; Ciro Indolfi
Journal:  Eur Heart J       Date:  2020-06-07       Impact factor: 29.983

8.  Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.

Authors:  Ian Huang; Michael Anthonius Lim; Raymond Pranata
Journal:  Diabetes Metab Syndr       Date:  2020-04-17

9.  Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.

Authors:  Ian Huang; Raymond Pranata
Journal:  J Intensive Care       Date:  2020-05-24

10.  Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression.

Authors:  Raymond Pranata; Ian Huang; Michael Anthonius Lim; Eka Julianta Wahjoepramono; Julius July
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

View more
  11 in total

Review 1.  Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings.

Authors:  William J Brady; Summer Chavez; Michael Gottlieb; Stephen Y Liang; Brandon Carius; Alex Koyfman; Brit Long
Journal:  Am J Emerg Med       Date:  2022-04-27       Impact factor: 4.093

2.  Out-of-hospital cardiac arrest treated by emergency medical service teams during COVID-19 pandemic: A retrospective cohort study.

Authors:  Magdalena J Borkowska; Jacek Smereka; Kamil Safiejko; Klaudiusz Nadolny; Maciej Maslanka; Krzysztof J Filipiak; Milosz J Jaguszewski; Lukasz Szarpak
Journal:  Cardiol J       Date:  2020-11-03       Impact factor: 2.737

3.  Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19.

Authors:  Eugene Yuriditsky; Oscar J L Mitchell; Shari B Brosnahan; Nathaniel R Smilowitz; Karsten W Drus; Anelly M Gonzales; Yuhe Xia; Sam Parnia; James M Horowitz
Journal:  Resusc Plus       Date:  2020-11-21

4.  Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Indriwanto Sakidjan Atmosudigdo; Raymond Pranata; Michael Anthonius Lim; Joshua Henrina; Emir Yonas; Rachel Vania; Basuni Radi
Journal:  J Clin Exp Hepatol       Date:  2021-02-08

5.  Epidemiological pattern of orthopaedic fracture during the COVID-19 pandemic: A systematic review and meta-analysis.

Authors:  Michael Anthonius Lim; Ketut Gede Mulyadi Ridia; Raymond Pranata
Journal:  J Clin Orthop Trauma       Date:  2020-12-30

6.  Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Indriwanto Sakidjan Atmosudigdo; Michael Anthonius Lim; Basuni Radi; Joshua Henrina; Emir Yonas; Rachel Vania; Raymond Pranata
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-03-24

7.  Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture - A systematic review and meta-analysis.

Authors:  Michael Anthonius Lim; Raymond Pranata
Journal:  J Clin Orthop Trauma       Date:  2020-09-17

8.  Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 - A systematic review and meta-analysis.

Authors:  Ahmad Fariz Malvi Zamzam Zein; Wilson Matthew Raffaello
Journal:  Prim Care Diabetes       Date:  2021-12-13       Impact factor: 2.459

9.  Effect of large-scale disasters on bystander-initiated cardiopulmonary resuscitation in family-witnessed, friend-witnessed and colleague-witnessed out-of-hospital cardiac arrest: a retrospective analysis of prospectively collected, nationwide, population-based data.

Authors:  Tomoyuki Ushimoto; Kohei Takada; Akira Yamashita; Hideki Morita; Yukihiro Wato; Hideo Inaba
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

10.  "COVID-19: diagnosis, management and prognosis": a new topical collection of Internal and Emergency Medicine.

Authors:  Riccardo Polosa; Michele Spinicci; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2020-07-30       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.